Ting-Ting Pan1, Feng Pan2, Wei Gao1, Shan-Shan Hu3, Di Wang4. 1. Department of Anesthesiology, Pain Clinic, First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China. 2. Menzies Institute for Medical Research, University of Tasmania, Private Bag 23, Hobart, TAS, 7000, Australia. 3. Institute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China. 4. Department of Anesthesiology, Pain Clinic, First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China. di.wang@ustc.edu.cn.
Abstract
PURPOSE OF REVIEW: Chronic pain in osteoarthritis (OA) is characterized by pain sensitization, which involves both peripheral and central mechanisms. Studies suggest synovial macrophage and spinal microglia are implicated in pain sensitization in OA. We, therefore, reviewed the evidence of whether synovial macrophage and spinal microglia facilitated pain sensitization at diverse levels and how this event occurred in OA. RECENT FINDINGS: Peripherally, joint inflammation is now believed to be a source of OA-related pain. Synovial macrophages accumulate in OA inflamed synovium and display a pro-inflammatory phenotype. Abundant macrophage-derived pro-inflammatory cytokines and other pain-causing substance facilitate hyperexcitation of primary sensory neuron in OA-related pain. Thus, activated synovial macrophage was considered a predictor for phenotyping of OA pain clinically. In response to affected joint-derived strong nociception, aberrant neuronal excitability is often associated with the hyperactivity of microglia in the spinal dorsal horn, thereby leading to central sensitization. Hyperactivity of synovial macrophage and spinal microglia underlies the mechanisms of pain sensitization at the peripheral and central level in OA. This concept provides not only a clinically relevant strategy for identifying the phenotype of OA-related pain but also has the potential to develop individualized interventions for OA, particularly in those patients with hyperactivity of macrophage and microglia.
PURPOSE OF REVIEW: Chronic pain in osteoarthritis (OA) is characterized by pain sensitization, which involves both peripheral and central mechanisms. Studies suggest synovial macrophage and spinal microglia are implicated in pain sensitization in OA. We, therefore, reviewed the evidence of whether synovial macrophage and spinal microglia facilitated pain sensitization at diverse levels and how this event occurred in OA. RECENT FINDINGS: Peripherally, joint inflammation is now believed to be a source of OA-related pain. Synovial macrophages accumulate in OA inflamed synovium and display a pro-inflammatory phenotype. Abundant macrophage-derived pro-inflammatory cytokines and other pain-causing substance facilitate hyperexcitation of primary sensory neuron in OA-related pain. Thus, activated synovial macrophage was considered a predictor for phenotyping of OA pain clinically. In response to affected joint-derived strong nociception, aberrant neuronal excitability is often associated with the hyperactivity of microglia in the spinal dorsal horn, thereby leading to central sensitization. Hyperactivity of synovial macrophage and spinal microglia underlies the mechanisms of pain sensitization at the peripheral and central level in OA. This concept provides not only a clinically relevant strategy for identifying the phenotype of OA-related pain but also has the potential to develop individualized interventions for OA, particularly in those patients with hyperactivity of macrophage and microglia.
Authors: Yuqing Zhang; Michael Nevitt; Jingbo Niu; Cora Lewis; James Torner; Ali Guermazi; Frank Roemer; Charles McCulloch; David T Felson Journal: Arthritis Rheum Date: 2011-03
Authors: Eric Osgood; Jeremiah J Trudeau; Thomas A Eaton; Mark P Jensen; Arnold Gammaitoni; Lee S Simon; Nathaniel Katz Journal: Rheumatol Int Date: 2014-12-16 Impact factor: 2.631
Authors: Tuhina Neogi; Ali Guermazi; Frank Roemer; Michael C Nevitt; Joachim Scholz; Lars Arendt-Nielsen; Clifford Woolf; Jingbo Niu; Laurence A Bradley; Emily Quinn; Laura Frey Law Journal: Arthritis Rheumatol Date: 2016-03 Impact factor: 10.995
Authors: Laura A Frey-Law; Nicole L Bohr; Kathleen A Sluka; Keela Herr; Charles R Clark; Nicolas O Noiseux; John J Callaghan; M Bridget Zimmerman; Barbara A Rakel Journal: Pain Date: 2016-09 Impact factor: 7.926
Authors: Josue S Cardoso; Joseph L Riley; Toni Glover; Kimberly T Sibille; Emily J Bartley; Burel R Goodin; Hailey W Bulls; Matthew Herbert; Adriana S Addison; Roland Staud; David T Redden; Laurence A Bradley; Roger B Fillingim; Yenisel Cruz-Almeida Journal: Pain Date: 2016-09 Impact factor: 7.926